Zhengye Biotechnology Holding (ZYBT) Minority Interest (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Minority Interest for 3 consecutive years, with $8.0 million the latest figure, recorded in Q4 2025.

• Quarterly Minority Interest fell 16.02% year-over-year to $8.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.0 million (down 16.02% YoY) and the FY2025 annual result came in at $8.1 million, down 13.47% from the prior year.
• Minority Interest fell to $8.0 million in Q4 2025 per ZYBT's latest filing, from $9.2 million in the prior quarter.
• Over the last five years, Minority Interest for ZYBT reached as high as $9.5 million in Q4 2024 and fell as low as $8.0 million in Q4 2025.
• A 3-year average of $9.0 million and a median of $9.2 million in 2023 frame the typical range for Minority Interest.
• Annual changes were most pronounced in 2024 — Minority Interest rose 3.49% — and 2025, when it fell 16.02%.
• Year by year, Minority Interest stood at $9.2 million in 2023, then climbed by 3.49% to $9.5 million in 2024, then fell by 16.02% to $8.0 million in 2025.
• According to Business Quant data, Minority Interest over the past three periods registered $8.0 million, $9.2 million, and $9.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.